Another 5,000 doses of Remdesivir to arrive in Moldova
Remdesivir
The director general of the Agency for Medicines and Medical Devices, Eremei Priseajniuc, signed today the authorization for the import of another 5,000 vials of Remdesivir, this being the first medicine authorized in the USA and EU for the treatment of COVID-19.
This batch of Remdesivir, with the trade name Desrem, produced by the pharmaceutical company Mylan, the Netherlands, is imported by Tetis International CO SRL and is scheduled to arrive in Chisinau in the near future.
In the Republic of Moldova, the preparation Remdesivir is provided in the Provisional National Clinical Protocol “New type coronavirus infection”, used in the treatment of patients infected with SARS VOC-2 virus.
We remind you that, previously, the Agency for Medicines and Medical Devices authorized the import for the first time of about 2000 bottles of Remdesivir, with the trade name Covifor.
This batch of Remdesivir, with the trade name Desrem, produced by the pharmaceutical company Mylan, the Netherlands, is imported by Tetis International CO SRL and is scheduled to arrive in Chisinau in the near future.
In the Republic of Moldova, the preparation Remdesivir is provided in the Provisional National Clinical Protocol “New type coronavirus infection”, used in the treatment of patients infected with SARS VOC-2 virus.
We remind you that, previously, the Agency for Medicines and Medical Devices authorized the import for the first time of about 2000 bottles of Remdesivir, with the trade name Covifor.